Home
HelpTest ID FBMO MVista Blastomyces Quantitative Antigen, Fluid
Specimen Required
Submit only one of the following:
Specimen Type: CSF or Bronchoalveolar Fluid
Container/Tube: Sterile leak-proof container
Specimen Volume: 2 mL
Collection Instructions:
CSF: Collect 2 mL of spinal fluid (CSF) in sterile leak-proof container. Send refrigerated in a plastic screw cap vial.
Bronchoalveolar Lavage: Collect 2 mL in sterile leak-proof container. Send refrigerated in a plastic screw cap vial.
NOTE:
1. Specimen type is required.
2. Separate order required for each specimen.
3. Sputolysin, sodium hydroxide, and potassium hydroxide treatment degrade the analyte detected in the assay.
Secondary ID
75510Method Name
Quantitative Sandwich Enzyme Immunoassay (EIA)
Reporting Name
MVista Blastomyces Ag, FluidSpecimen Type
VariesSpecimen Minimum Volume
CSF: 0.8 mL; BAL: 0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Varies | Refrigerated (preferred) | 14 days |
| Ambient | 14 days | |
| Frozen | ||
Reference Values
Reference Interval: None Detected
Reportable Range: 0.31 ng/mL – 20.00 ng/mL
Results above 20.00 ng/mL are reported as 'Positive, Above the Limit of Quantification'
Cautions
Cross-reactions are seen with histoplasmosis, paracoccidioidomycosis, penicilliosis, less frequently in coccidiooidomycosis, rarely in aspergillosis and possibly sporotrichosis.
Sputolysin, sodium hydroxide, and potassium hydroxide treatment degrade the analyte detected in the assay.
Day(s) Performed
Monday through Saturday
Report Available
3 to 5 daysPerforming Laboratory
MiraVista DiagnosticsTest Classification
This test was developed and its performance characteristics determined by MiraVista Diagnostics. It has not been cleared or approved by the FDA; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.CPT Code Information
87449